Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelets Present Antigen in the Context of MHC Class I
2012
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Implementation experience during an eighteen month intervention to improve paediatric and newborn care in Kenyan district hospitals
2009
An intervention to improve paediatric and newborn care in Kenyan district hospitals: Understanding the context
2009
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Developing a tool to measure health worker motivation in district hospitals in Kenya
2009
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
A Systematic Review of Healthcare Applications for Smartphones
2012 Standout
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
2020 Standout
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
2009
Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013/ALFQ in rhesus macaques (Macaca mulatta) of Indian and Chinese origin
2019
Developing and introducing evidence based clinical practice guidelines for serious illness in Kenya
2008
Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis
2010
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa
2006
Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture
2021
Sickle cell disease
2017
Lipid nanoparticles for mRNA delivery
2021 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
2011
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
2011
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Stimulation of Suicidal Erythrocyte Death by Artesunate
2014
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
2016
Laboratory Medicine in Africa: A Barrier to Effective Health Care
2006
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
2014
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
2022 StandoutNobel
The RTS,S malaria vaccine
2010
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection
2016
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial
2007
Malaria
2013 Standout
Health systems research in a low-income country: easier said than done
2008
Documenting the experiences of health workers expected to implement guidelines during an intervention study in Kenyan hospitals
2009
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)
2019
Current approaches to malaria vaccines
2022
Sepsis and septic shock
2018 Standout
Mortality after Fluid Bolus in African Children with Severe Infection
2011
Randomized Trial of Volume Expansion with Albumin or Saline in Children with Severe Malaria: Preliminary Evidence of Albumin Benefit
2005
Novel approaches for vaccine development
2021
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Contextual influences on health worker motivation in district hospitals in Kenya
2009 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Millennium Development Goals 4 and 5: progress and challenges
2013
Sickle-cell disease
2010 Standout
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
2012
Regulation of type I interferon responses
2013 Standout
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
2014
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
2011
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2014 Standout
Hospital-acquired neonatal infections in developing countries
2005
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
New Perspectives on Chinese Herbal Medicine (Zhong‐Yao) Research and Development
2010
Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
2015
Enhancing the routine health information system in rural southern Tanzania: successes, challenges and lessons learned
2011
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Toll-Like Receptor 7 Mediates Early Innate Immune Responses to Malaria
2013
RTS,S/AS01 vaccine (Mosquirix™): an overview
2019
Resolution of Diols via Catalytic Asymmetric Acetalization
2015 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
Nucleophilic Chiral Amines as Catalysts in Asymmetric Synthesis
2003
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
2016
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Interferon signatures in immune disorders and disease
2012
Point-of-Care Diagnostics for Global Health
2008 Standout
Breakdown of Phosphatidylserine Asymmetry Following Treatment of Erythrocytes with Lumefantrine
2014
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
2014
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
2010
Works of Bernhards Ogutu being referenced
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
2011
Implementation of a structured paediatric admission record for district hospitals in Kenya – results of a pilot study
2006
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine
2011
Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya
2004
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events
2015
Delivery of paediatric care at the first-referral level in Kenya
2004
Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study
2014
Burden, Features, and Outcome of Neurological Involvement in Acute Falciparum Malaria in Kenyan Children
2007
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
2009
Cerebral Malaria
2003
Artemether and lumefantrine for the treatment of uncomplicatedPlasmodium falciparummalaria in sub-Saharan Africa
2013
Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis
2016
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
2008
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems
2012
Systematic comparison of two methods to measure parasite density from malaria blood smears
2006
Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital.
2003
Management of Seizures in Children with Falciparum Malaria
2004